JP7159188B2 - ナビゲーション課題を使用するバイオマーカーの識別およびナビゲーション課題を使用する治療のためのプラットフォーム - Google Patents

ナビゲーション課題を使用するバイオマーカーの識別およびナビゲーション課題を使用する治療のためのプラットフォーム Download PDF

Info

Publication number
JP7159188B2
JP7159188B2 JP2019551925A JP2019551925A JP7159188B2 JP 7159188 B2 JP7159188 B2 JP 7159188B2 JP 2019551925 A JP2019551925 A JP 2019551925A JP 2019551925 A JP2019551925 A JP 2019551925A JP 7159188 B2 JP7159188 B2 JP 7159188B2
Authority
JP
Japan
Prior art keywords
individual
data
navigation
task
environment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019551925A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020518043A5 (https=
JP2020518043A (ja
Inventor
アシュリー・マテウス
ティティイマエア・アライリマ
ジェイソン・ジョンソン
マシュー・オマーニック
クリスティアン・デラー
ヒューゴ・スパイアーズ
ウォルター・エドワード・マルトゥッチ
Original Assignee
アキリ・インタラクティヴ・ラブズ・インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アキリ・インタラクティヴ・ラブズ・インコーポレイテッド filed Critical アキリ・インタラクティヴ・ラブズ・インコーポレイテッド
Publication of JP2020518043A publication Critical patent/JP2020518043A/ja
Publication of JP2020518043A5 publication Critical patent/JP2020518043A5/ja
Priority to JP2022163176A priority Critical patent/JP7442596B2/ja
Application granted granted Critical
Publication of JP7159188B2 publication Critical patent/JP7159188B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A61B5/168—Evaluating attention deficit, hyperactivity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
    • A61B5/4064—Evaluating the brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4082—Diagnosing or monitoring movement diseases, e.g. Parkinson, Huntington or Tourette
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient; User input means
    • A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient; User input means
    • A61B5/7475—User input or interface means, e.g. keyboard, pointing device, joystick
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/20—Protein or domain folding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/70—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Developmental Disabilities (AREA)
  • Psychology (AREA)
  • Physiology (AREA)
  • Neurosurgery (AREA)
  • Data Mining & Analysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Databases & Information Systems (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Social Psychology (AREA)
  • Evolutionary Biology (AREA)
  • Biotechnology (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Educational Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
JP2019551925A 2016-12-13 2017-12-13 ナビゲーション課題を使用するバイオマーカーの識別およびナビゲーション課題を使用する治療のためのプラットフォーム Active JP7159188B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022163176A JP7442596B2 (ja) 2016-12-13 2022-10-11 ナビゲーション課題を使用するバイオマーカーの識別およびナビゲーション課題を使用する治療のためのプラットフォーム

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662433769P 2016-12-13 2016-12-13
US62/433,769 2016-12-13
PCT/US2017/066214 WO2018112103A1 (en) 2016-12-13 2017-12-13 Platform for identification of biomarkers using navigation tasks and treatments using navigation tasks

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022163176A Division JP7442596B2 (ja) 2016-12-13 2022-10-11 ナビゲーション課題を使用するバイオマーカーの識別およびナビゲーション課題を使用する治療のためのプラットフォーム

Publications (3)

Publication Number Publication Date
JP2020518043A JP2020518043A (ja) 2020-06-18
JP2020518043A5 JP2020518043A5 (https=) 2021-01-28
JP7159188B2 true JP7159188B2 (ja) 2022-10-24

Family

ID=62559169

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019551925A Active JP7159188B2 (ja) 2016-12-13 2017-12-13 ナビゲーション課題を使用するバイオマーカーの識別およびナビゲーション課題を使用する治療のためのプラットフォーム
JP2022163176A Active JP7442596B2 (ja) 2016-12-13 2022-10-11 ナビゲーション課題を使用するバイオマーカーの識別およびナビゲーション課題を使用する治療のためのプラットフォーム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022163176A Active JP7442596B2 (ja) 2016-12-13 2022-10-11 ナビゲーション課題を使用するバイオマーカーの識別およびナビゲーション課題を使用する治療のためのプラットフォーム

Country Status (7)

Country Link
US (2) US12138069B2 (https=)
EP (1) EP3555841A4 (https=)
JP (2) JP7159188B2 (https=)
KR (1) KR102525394B1 (https=)
CN (1) CN110603550A (https=)
AU (1) AU2017376455A1 (https=)
WO (1) WO2018112103A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12399564B2 (en) 2012-08-31 2025-08-26 Blue Goji Llc Treatment of neurological functioning and conditions using computer-assisted dual-task methodology
US11914776B2 (en) 2012-08-31 2024-02-27 Blue Goji Llc System and method for evaluation, detection, conditioning, and treatment of neurological functioning and conditions
KR20200128555A (ko) * 2018-03-04 2020-11-13 아킬리 인터랙티브 랩스 인크. 면역-매개 및 신경-퇴행성 장애를 표적으로 하는 인지 스크린, 모니터 및 인지 치료
US12354729B2 (en) 2018-03-04 2025-07-08 Akili Interactive Labs, Inc. Cognitive screens, monitor and cognitive treatments targeting immune-mediated and neuro-degenerative disorders
CN111990971B (zh) * 2020-09-02 2023-07-07 中国科学院心理研究所 一种基于触屏操作箱视觉空间配对学习的实验与分析方法
CN116077027B (zh) * 2023-02-27 2024-06-28 首都医科大学附属北京友谊医院 一种视觉空间认知能力测试系统及存储介质
CN116363404B (zh) * 2023-03-30 2023-11-21 哈尔滨工业大学 一种识别和量化脑自发活动预测性地图样表征的方法
KR20240152448A (ko) * 2023-04-12 2024-10-22 가톨릭대학교 산학협력단 노인 우울증 환자의 예후를 예측하는 장치 및 그 방법
US12362059B2 (en) 2023-07-17 2025-07-15 NXTech Inc Neurostimulation with gamified self-control training exercises
WO2025081044A1 (en) * 2023-10-13 2025-04-17 Cognivue, Inc. Cognitive screening test for detecting preclinical alzheimer's disease

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007532219A (ja) 2004-04-13 2007-11-15 ケンブリッジ ユニバーシティー テクニカル サービシズ リミティッド 神経認知疾患を評価するための方法
US20080280276A1 (en) 2007-05-09 2008-11-13 Oregon Health & Science University And Oregon Research Institute Virtual reality tools and techniques for measuring cognitive ability and cognitive impairment
JP2014535080A (ja) 2011-11-16 2014-12-25 ヴェロニク・デボラ・ボーボ 記憶を改善するためのコンピュータ生成三次元仮想現実環境
US20160078780A1 (en) 2014-09-15 2016-03-17 The Arizona Board Of Regents For And On Behalf Of The University Of Arizona Method and System for Aerobic and Cognitive Training
US20160262680A1 (en) 2015-03-12 2016-09-15 Akili Interactive Labs, Inc. Processor Implemented Systems and Methods for Measuring Cognitive Abilities
WO2016154682A1 (en) 2015-04-02 2016-10-06 Crc For Mental Health Ltd Method for predicting risk of cognitive deterioration

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2503658A1 (en) 2002-11-05 2004-05-21 University Of Rochester Medical Center Method for assessing navigational capacity
US20120108909A1 (en) 2010-11-03 2012-05-03 HeadRehab, LLC Assessment and Rehabilitation of Cognitive and Motor Functions Using Virtual Reality
CA2720892A1 (en) 2010-11-12 2012-05-12 The Regents Of The University Of California Enhancing cognition in the presence of distraction and/or interruption
ES2831648T3 (es) * 2010-11-24 2021-06-09 Digital Artefacts Llc Sistemas y métodos para evaluar la función cognitiva
US20120238837A1 (en) * 2011-03-16 2012-09-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware System, devices, and methods for real-time monitoring of cerebrospinal fluid for markers of progressive conditions
ES2928091T3 (es) * 2011-10-09 2022-11-15 Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct Realidad virtual para el diagnóstico de trastornos de movimiento
WO2013120075A1 (en) * 2012-02-09 2013-08-15 Anthrotronix, Inc. Performance assessment tool
US20150116316A1 (en) 2013-10-28 2015-04-30 Brown University Virtual reality methods and systems
GB201322094D0 (en) * 2013-12-13 2014-01-29 Electrophoretics Ltd Methods and compositions relating to alzheimers disease
WO2015179522A1 (en) 2014-05-21 2015-11-26 Akili Interactive Labs, Inc. Processor-implemented systems and methods for enhancing cognitive abilities by personalizing cognitive training regimens
US20160125748A1 (en) 2014-11-04 2016-05-05 John Wesson Ashford Memory test for Alzheimer's disease
US10449359B2 (en) 2015-01-24 2019-10-22 The Trustees Of The University Of Pennsylvania Method and apparatus for improving cognitive performance
US10661099B2 (en) * 2015-06-16 2020-05-26 Eugene R. Moore Treatment of alzheimer's disease
US20190330335A1 (en) * 2015-10-06 2019-10-31 Alector Llc Anti-trem2 antibodies and methods of use thereof
EP3405185A4 (en) * 2016-01-19 2019-09-18 Thomas Blumenthal BIOMARKERS FOR DOWN SYNDROME AND USES THEREOF
EP3531915B1 (en) 2016-10-24 2024-12-04 Akili Interactive Labs, Inc. Cognitive platform configured as a biomarker or other type of marker
US10401369B2 (en) * 2016-11-08 2019-09-03 Magqu Co. Ltd. Method for discriminating Parkinson's disease dementia from Parkinson's disease with normal cognition

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007532219A (ja) 2004-04-13 2007-11-15 ケンブリッジ ユニバーシティー テクニカル サービシズ リミティッド 神経認知疾患を評価するための方法
US20080280276A1 (en) 2007-05-09 2008-11-13 Oregon Health & Science University And Oregon Research Institute Virtual reality tools and techniques for measuring cognitive ability and cognitive impairment
JP2014535080A (ja) 2011-11-16 2014-12-25 ヴェロニク・デボラ・ボーボ 記憶を改善するためのコンピュータ生成三次元仮想現実環境
US20160078780A1 (en) 2014-09-15 2016-03-17 The Arizona Board Of Regents For And On Behalf Of The University Of Arizona Method and System for Aerobic and Cognitive Training
US20160262680A1 (en) 2015-03-12 2016-09-15 Akili Interactive Labs, Inc. Processor Implemented Systems and Methods for Measuring Cognitive Abilities
WO2016154682A1 (en) 2015-04-02 2016-10-06 Crc For Mental Health Ltd Method for predicting risk of cognitive deterioration

Also Published As

Publication number Publication date
AU2017376455A1 (en) 2019-06-13
CN110603550A (zh) 2019-12-20
WO2018112103A1 (en) 2018-06-21
US12138069B2 (en) 2024-11-12
JP2020518043A (ja) 2020-06-18
JP7442596B2 (ja) 2024-03-04
EP3555841A1 (en) 2019-10-23
KR20190091354A (ko) 2019-08-05
US20250064378A1 (en) 2025-02-27
JP2023015042A (ja) 2023-01-31
EP3555841A4 (en) 2020-05-20
CA3046789A1 (en) 2018-06-21
KR102525394B1 (ko) 2023-04-24
US20190343447A1 (en) 2019-11-14

Similar Documents

Publication Publication Date Title
JP7442596B2 (ja) ナビゲーション課題を使用するバイオマーカーの識別およびナビゲーション課題を使用する治療のためのプラットフォーム
JP7125390B2 (ja) バイオマーカーまたは他のタイプのマーカーとして構成される認知プラットフォーム
JP7267910B2 (ja) 適応型応答デッドライン手順において信号検出メトリックを実施するためのプラットフォーム
US12354729B2 (en) Cognitive screens, monitor and cognitive treatments targeting immune-mediated and neuro-degenerative disorders
JP7146800B2 (ja) プラットフォーム間でデータを安全に収集、分析、及び共有するための分散ネットワーク
JP2022117988A (ja) 生理学的コンポーネントに接続された認知プラットフォーム
KR20200128555A (ko) 면역-매개 및 신경-퇴행성 장애를 표적으로 하는 인지 스크린, 모니터 및 인지 치료
JP2023025083A (ja) コンピュータ化された喚起要素を含む認知プラットフォーム
JP2022502789A (ja) 認知処置を最適化するための努力メトリックを導出するための認知プラットフォーム
US11839472B2 (en) Platforms to implement signal detection metrics in adaptive response-deadline procedures
JP2022506651A (ja) 情動障害のスクリーニングおよび治療のための顔の表情検出
WO2018222729A1 (en) Platform for identification of biomarkers using navigation tasks and treatments based thereon
US20240081706A1 (en) Platforms to implement signal detection metrics in adaptive response-deadline procedures
CA3046789C (en) Platform for identification of biomarkers using navigation tasks and treatments using navigation tasks
HK40019863A (en) Platform for identification of biomarkers using navigation tasks and treatments using navigation tasks
HK40038025A (en) Cognitive screens, monitor and cognitive treatments targeting immune-mediated and neuro-degenerative disorders
HK40045201A (en) Cognitive platform for deriving effort metric for optimizing cognitive treatment

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201211

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201211

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20211224

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220131

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220427

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220623

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220912

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20221012

R150 Certificate of patent or registration of utility model

Ref document number: 7159188

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250